Kate Bingham describes the type of investments SV makes, which was in the news this week for being the founding investor of the neuropsych company Draig Therapeutics that exited stealth with $140M. Plus, having previously served as the chair of the government's Vaccine Taskforce during COVID, she also shares her thoughts on the evironment in the UK and the MHRA.
View all episodes
By BiotechTV
4.3
66 ratings
Kate Bingham describes the type of investments SV makes, which was in the news this week for being the founding investor of the neuropsych company Draig Therapeutics that exited stealth with $140M. Plus, having previously served as the chair of the government's Vaccine Taskforce during COVID, she also shares her thoughts on the evironment in the UK and the MHRA.
3,223 Listeners
1,902 Listeners
123 Listeners
324 Listeners
61 Listeners
9,899 Listeners
86 Listeners
34 Listeners
353 Listeners
19 Listeners
60 Listeners
514 Listeners
41 Listeners
0 Listeners
4 Listeners
2 Listeners
6 Listeners
46 Listeners